We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
-5.08%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.82B
AUM Growth
-$690M
Cap. Flow
-$124M
Cap. Flow %
-2.58%
Top 10 Hldgs %
17.51%
Holding
1,588
New
254
Increased
693
Reduced
409
Closed
141

Top Buys

Rank Stock Value
1
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
+$50.6M
2
CAT icon
Caterpillar
CAT
+$27M
3
ADI icon
Analog Devices
ADI
+$22.8M
4
CSX icon
CSX Corp
CSX
+$20.1M
5
PTY icon
PIMCO Corporate & Income Opportunity Fund
PTY
+$15M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$24.6M
2
BCX icon
BlackRock Resources & Commodities Strategy Trust
BCX
+$22.3M
3
MXIM
Maxim Integrated Products
MXIM
+$21.2M
4
NFJ
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
+$21.1M
5
VVR icon
Invesco Senior Income Trust
VVR
+$19.6M

Sector Composition

Rank Sector Weight
1 Technology 27.8%
2 Consumer Discretionary 25.32%
3 Communication Services 11.6%
4 Industrials 6.01%
5 Financials 5.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICPT
1351
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$11K ﹤0.01%
765
+10
+1% +$160
EPZM
1352
DELISTED
Epizyme, Inc
EPZM
$11K ﹤0.01%
2,340
+20
+0.9% +$121
ALT icon
1353
Altimmune
ALT
$599M
$10K ﹤0.01%
910
+35
+4% +$426
FABC
1354
Fabric.AI Inc
FABC
$18.4M
$10K ﹤0.01%
24
– –
DVYE icon
1355
iShares Emerging Markets Dividend ETF
DVYE
$1.22B
$10K ﹤0.01%
+276
New +$10.7K
GERN icon
1356
Geron
GERN
$949M
$10K ﹤0.01%
7,335
+85
+1% +$113
KPTI icon
1357
Karyopharm Therapeutics
KPTI
$48M
$10K ﹤0.01%
115
+1
+0.9% +$104
PAHC icon
1358
Phibro Animal Health
PAHC
$1.39B
$10K ﹤0.01%
465
– –
RLMD icon
1359
Relmada Therapeutics
RLMD
$527M
$10K ﹤0.01%
400
+20
+5% +$535
RNAC icon
1360
Cartesian Therapeutics
RNAC
$268M
$10K ﹤0.01%
88
+2
+2% +$242
QTTB icon
1361
Q32 Bio
QTTB
$464M
$10K ﹤0.01%
73
+1
+1% +$127
NKLA
1362
DELISTED
Nikola Corporation Common Stock
NKLA
$10K ﹤0.01%
32
– –
PSTX
1363
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$10K ﹤0.01%
1,425
+10
+0.7% +$86
ABUS icon
1364
Arbutus Biopharma
ABUS
$915M
$9K ﹤0.01%
2,265
+70
+3% +$233
ANIP icon
1365
ANI Pharmaceuticals
ANIP
$1.78B
$9K ﹤0.01%
290
– –
APLT
1366
DELISTED
Applied Therapeutics
APLT
$9K ﹤0.01%
595
– –
DNTH icon
1367
Dianthus Therapeutics
DNTH
$6.09B
$9K ﹤0.01%
83
– –
HNST icon
1368
The Honest Company
HNST
$586M
$9K ﹤0.01%
904
– –
KALV
1369
DELISTED
KalVista Pharmaceuticals
KALV
$9K ﹤0.01%
560
+5
+0.9% +$101
KZR
1370
DELISTED
Kezar Life Sciences
KZR
$9K ﹤0.01%
110
– –
LSF icon
1371
Laird Superfood
LSF
$47.8M
$9K ﹤0.01%
502
– –
XBIT icon
1372
XBiotech
XBIT
$69.2M
$9K ﹤0.01%
695
+10
+1% +$159
MRNS
1373
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$9K ﹤0.01%
835
– –
BFX
1374
DELISTED
BowFlex Inc.
BFX
$9K ﹤0.01%
980
– –
PRVB
1375
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$9K ﹤0.01%
1,450
+5
+0.3% +$32
53 54
55
56 57

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Penserra Capital Management held 1,588 positions worth $4.82B, down 13% from $5.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Penserra Capital Management's Q3 2021 filing shows 254 new, 693 increased, 409 reduced and 141 closed positions. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M. The largest sale was Baidu, an estimated $24.6M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Penserra Capital Management's largest Q3 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 5,364,893 shares worth $41.8M.
  • Penserra Capital Management added most to Analog Devices in Q3 2021, an estimated $22.8M increase.
  • Penserra Capital Management's biggest Q3 2021 reduction was Baidu, cutting an estimated $24.6M.
  • Penserra Capital Management fully exited BlackRock Resources & Commodities Strategy Trust in Q3 2021, selling an estimated $22.3M.
  • Penserra Capital Management's ten largest holdings make up 18% of its $4.82B portfolio in Q3 2021.
  • Penserra Capital Management opened 254 new positions and closed 141 in Q3 2021.
  • Penserra Capital Management's portfolio value fell 13% quarter-over-quarter to $4.82B.

Based on Penserra Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.